Healthtech deals decreased in clinical trial operations in H1 2022
There is an acceleration in growth from the 36.9% decrease in deals that occurred in H2 2021 relative to the…
By
There is an acceleration in growth from the 36.9% decrease in deals that occurred in H2 2021 relative to the…
ByGlobalData's deals database looks at mergers, acquisitions and venture capital and private equity investments.
ByThis marks a deceleration in growth from the 7.1% decrease in deals that occurred in H2 2021 relative to the…
ByGlobalData's deals database looks at mergers, acquisitions and venture capital and private equity investments taking place worldwide.
ByObvioHealth will leverage Dedalus’ data mining and analytics tools to carry out its research.
The partnership aims to easily incorporate speech measures to Koneksa studies and digital biomarker development programmes.
The proceeds from the funding will be utilised to support the Phase IIa expansion arms of EVICTION for cancers.
Debt offerings have seen a decrease of 37.5% from H2 2020 to H2 2021, an analysis of GlobalData's deals database…
ByThank you for subscribing to Clinical Trials Arena